Liping Ren

Neusoft (China)

Papers

1

Total Citations

4

H-Index

1

About

Dr. Liping Ren is a leading computational biologist whose research focuses on cancer genomics, drug resistance mechanisms, and single-cell transcriptomics. Her most significant contribution is the development of CellResDB, a pioneering patient-level single-cell transcriptomics database that systematically deciphers the molecular underpinnings of cancer therapy resistance. Unlike previous resources limited to bulk RNA-seq data or lacking clinical annotations, CellResDB provides unprecedented resolution by integrating single-cell data with rich clinical metadata, enabling researchers to identify resistance-driving cell populations and pathways at an individual patient level. This work has already garnered 4 citations since its 2025 publication, reflecting its immediate impact on the field. Dr. Ren’s research addresses a critical gap in oncology—understanding why treatments fail—by offering a scalable, open-access platform for exploring resistance mechanisms across diverse cancer types. Her innovative approach bridges single-cell biology and translational medicine, empowering the scientific community to develop more effective, personalized therapeutic strategies. Through CellResDB, Dr. Ren is shaping the future of precision oncology and drug resistance research.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Deciphering cancer therapy resistance via patient-level single-cell transcriptomics with CellResDB
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Neusoft (China)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago